ReviewCureus2026
Graft-Site Morbidity in Anterior Cruciate Ligament (ACL) Reconstruction: A Scoping Review of Assessment Techniques and Outcomes.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graft-site morbidity is a critical yet often overlooked aspect of anterior cruciate ligament reconstruction (ACLR). While autografts such as bone-patellar tendon-bone (BPTB) and quadriceps tendon (QT) have been shown to provide effective mechanical stability, the functional and quality-of-life outcomes associated with graft harvesting location warrant greater attention. This scoping review evaluates the existing methodologies for assessing graft-site morbidity, focusing on anterior knee pain, paresthesia, and muscle deficits. Articles were screened from January 1, 2000, to June 12, 2024, returning 609 unique references to graft-site morbidity. A systematic search identified 43 studies meeting inclusion criteria, revealing significant variability in assessment methods and reporting standards. This review underscores the need for a uniformly administered series of techniques to measure graft-site morbidity, enabling meaningful comparisons and improving patient-centric surgical decision-making. Future investigations should prioritize standardizing assessment tools to assess graft selection and optimize holistic patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.